<DOC>
	<DOCNO>NCT01255423</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Diclofenac Sodium Topical ( DSG ) 1 % compare placebo apply four time day subject acute ankle sprain 'in-use ' condition , particular regard pain relief .</brief_summary>
	<brief_title>Efficacy Safety Diclofenac Sodium Topical Gel 1 % Applied 4 Times Daily Subjects With Acute Ankle Sprain</brief_title>
	<detailed_description />
	<mesh_term>Ankle Injuries</mesh_term>
	<mesh_term>Sprains Strains</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Inclusion criterion : 1 . Male female age 18 year . 2 . Acute sprain lateral ankle , Grade III , meet baseline pain intensity level . 3 . Injury within past 12 hour . Exclusion criterion : 1 . Pain medication take within 6 hour precede randomization . 2 . During past 3 month : Grade IIII sprain ankle . 3 . During past 6 month : Grade IIIII sprain , significant injury ( fracture tear ligament ) , surgery ( except skin nail ) ankle foot . 4 . Pain instability ankle attributable previous ankle sprain trauma . 5 . Ankle sprain attributable known disease affect ligament , ligament hyperlaxity due connective tissue disease ( e.g. , Marfan 's syndrome , Down 's syndrome , EhlersDanlos syndrome ) . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Ankle sprain , soft tissue injury</keyword>
</DOC>